Wiedmann, M. W., & Mössner, J. (2012). Safety and Efficacy of Sunitinib in Patients with Unresectable Pancreatic Neuroendocrine Tumors. Libertas Academica.
Citación estilo ChicagoWiedmann, Marcus W., y Joachim Mössner. Safety and Efficacy of Sunitinib in Patients With Unresectable Pancreatic Neuroendocrine Tumors. Libertas Academica, 2012.
Cita MLAWiedmann, Marcus W., y Joachim Mössner. Safety and Efficacy of Sunitinib in Patients With Unresectable Pancreatic Neuroendocrine Tumors. Libertas Academica, 2012.
Precaución: Estas citas no son 100% exactas.